U.S. stock market update: Illumina up 7.02%

U.S. Stock Market Midday Update Illumina rose 7.02%, with increased trading volume. Based on recent important news: On July 21, Illumina received analyst attention; although rated as hold, the market held an optimistic view on its future performance, driving the stock price up 7.02%. On July 22, the easing of U.S.-China relations improved market sentiment, with favorable factors pushing the stock market up, indirectly boosting Illumina's stock price. On July 21, expectations in the luxury housing market improved, investor confidence strengthened, and capital flowed into the stock market, benefiting Illumina. Stocks with High Trading Volume in the Industry Medpace Holdings rose 56.69%, with a trading volume of $1.698 billion. Based on recent key news: On July 22, Medpace released its second-quarter financial report, with revenue and net profit exceeding expectations, reporting revenue of $603.3 million and net profit of $90.26 million, leading to a 45% increase in stock price. On July 22, Medpace raised its full-year revenue and earnings per share guidance for 2025, expecting revenue between $2.42 billion and $2.52 billion, and earnings per share between $13.76 and $14.53, resulting in a significant stock price surge. On July 22, Medpace announced a $518.5 million stock buyback, enhancing market confidence and driving the stock price up. Danaher rose 0.71%, with increased trading volume. Based on recent important news: On July 23, Danaher reported second-quarter sales of $5.94 billion, exceeding analyst expectations of $5.84 billion, pushing the stock price up 0.71%. On July 23, Danaher raised its annual profit forecast due to pharmaceutical demand and recovery in the Chinese market, with a positive market reaction. On July 22, Danaher announced the appointment of Matthew Gugino as the new Chief Financial Officer, with the management change seen as a positive signal. Thermo Fisher Scientific rose 5.54%, with increased trading volume. Based on recent important news: On July 21, Thermo Fisher Scientific received a moderate buy rating from analysts; although not listed as a top recommended stock, the market remained optimistic about its future performance, leading to a 5.54% increase in stock price. On July 22, the easing of U.S.-China relations allowed the market to digest favorable factors, with improved expectations in the luxury housing market driving related stocks up. On July 23, analysts continued to recommend other stocks, but Thermo Fisher Scientific maintained its moderate buy rating, enhancing market confidence. Stocks with High Market Capitalization in the Industry Agilent Technologies rose 3.88%, with increased trading volume. Based on recent important news: On July 20, Agilent Technologies was not included in the list of five stocks recommended by top analysts; despite its moderate buy rating, this may lead investors to reassess its investment value, resulting in a 3.88% increase in stock price On July 21, concerns about tariffs and economic recession eased, boosting investor confidence and driving stock prices up. On July 22, analysts' optimism about the market increased, further propelling the rise in stock prices